Tabaac BJ
Reno School of Medicine, University of Nevada, Reno, NV.
ArticleMescaline
Psychedelic Therapy: A Primer for Primary Care Clinicians-Mescaline.
ArticleIbogaine
Clinical improvement following an integrative iboga microdosing protocol in post-concussive and hypoxic brain injury syndromes: a case series.
ArticleDMT
Psychedelic Therapy: A Primer for Primary Care Clinicians-5-Methoxy-N,N-Dimethyltryptamine.
PreprintMescaline
Psychedelic Therapy: A Primer for Primary Care Clinicians—Mescaline
PreprintDMT
Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT)
ArticleKetamine
Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends.
PreprintKetamine
Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends
ArticlePsychedelics
Examining the influence of team-based learning on medical students' comprehension and attitudes regarding psychedelic therapies.
ArticleLSD
Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD).
ArticlePsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
ArticleAyahuasca
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.
ArticlePsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.
ArticleKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine.
ArticleIbogaine
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine.
ArticleKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics.
ArticleMDMA
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
PreprintKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VII. Ketamine
PreprintKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VIII. The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
PreprintMDMA
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VI. 3,4-methylenedioxy-methamphetamine (MDMA)
PreprintIbogaine
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part V. Ibogaine
PreprintPsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part I. Historical Perspective and Overview
PreprintLSD
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part II. Lysergic acid diethylamide (LSD)
PreprintPsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part IV. Psilocybin
PreprintAyahuasca